Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BioPhero ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   17.2% 4.1% 6.5% 4.7% 4.6% 4.7% 18.0% 18.0%   Credit score (0-100)   12 51 38 47 46 44 7 7   Credit rating   BB BBB BBB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -6.6 1,619 1,655 5,136 -1,600 -3,590 0.0 0.0   EBITDA   -6.6 101 -4,164 -3,433 -13,603 -20,137 0.0 0.0   EBIT   -6.6 0.3 -4,666 -4,094 -14,973 -21,968 0.0 0.0   Pre-tax profit (PTP)   -6.6 0.0 -4,721.6 -4,164.0 -14,667.2 -22,109.4 0.0 0.0   Net earnings   -6.6 0.0 -4,721.6 -3,047.9 -14,667.2 -17,401.5 0.0 0.0   Pre-tax profit without non-rec. items   -6.6 0.0 -4,722 -4,164 -14,667 -22,109 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Tangible assets total   0.0 1,866 1,818 3,783 4,537 10,328 0.0 0.0   Shareholders equity total   43.4 3,848 10,301 14,703 66,697 85,099 -20,704 -20,704   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.8 0.0 20,704 20,704   Balance sheet total (assets)   43.4 8,422 12,873 27,745 70,274 89,985 0.0 0.0   Net Debt   -42.3 -6,072 -10,684 -21,553 -22,852 -58,904 20,704 20,704     See the entire balance sheet 1000.0 Volume  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -6.6 1,619 1,655 5,136 -1,600 -3,590 0.0 0.0   Gross profit growth   0.0% 0.0% 2.3% 210.3% 0.0% -124.3% 0.0% 0.0%   Employees   1 3 10 14 20 26 0 0   Employee growth %   0.0% 200.0% 233.3% 40.0% 42.9% 30.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   43 8,422 12,873 27,745 70,274 89,985 0 0   Balance sheet change%   0.0% 19,323.8% 52.9% 115.5% 153.3% 28.0% -100.0% 0.0%   Added value   -6.6 0.3 -4,666.1 -4,093.6 -14,973.2 -21,968.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 1,765 -549 1,305 -616 3,959 -10,328 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 0.0% -281.9% -79.7% 935.7% 612.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -15.3% 0.0% -43.8% -20.2% -29.4% -27.4% 0.0% 0.0%   ROI %   -15.3% 0.0% -66.0% -32.7% -35.1% -28.7% 0.0% 0.0%   ROE %   -15.3% 0.0% -66.7% -24.4% -36.0% -22.9% 0.0% 0.0%   1000.0 Solidity  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Equity ratio %   100.0% 45.7% 80.0% 78.0% 95.1% 94.6% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   636.7% -6,005.4% 256.6% 627.8% 168.0% 292.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 62,573.1% 38,941.7% 0.0% 0.0%   1000.0 Liquidity  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Quick Ratio   0.0 1.4 4.3 5.8 24.7 17.3 0.0 0.0   Current Ratio   0.0 1.4 4.3 1.8 23.3 19.1 0.0 0.0   Cash and cash equivalent   42.3 6,072.1 10,684.5 21,553.0 22,852.8 58,904.2 0.0 0.0   1000.0 Capital use efficiency  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 3,772.9 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   43.4 1,982.1 8,483.1 10,920.4 62,920.7 75,480.4 -10,352.2 -10,352.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2017/6 2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -7 0 -467 -292 -749 -845 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -7 34 -416 -245 -680 -774 0 0   EBIT / employee   -7 0 -467 -292 -749 -845 0 0   Net earnings / employee   -7 0 -472 -218 -733 -669 0 0